IP Library Granted Patent US 11,543,683
Granted Patent B2
US 11,543,683 · App. 16/938,145 · Granted Jan 3, 2023

Multifocal contact lens displaying improved vision attributes

Inventors: Shivkumar Mahadevan (Jacksonville, FL); Dawn D. Wright (St. Augustine, FL); Ronald J. Clark (Jacksonville, FL); Thomas R. Karkkainen (Orange Park, FL); Derek Nankivil (Jacksonville, FL)
Assignee: Johnson & Johnson Vision Care, Inc.
G02C7/047G02C7/049G02C7/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,543,683
App. No.
16/938,145
Granted
Jan 3, 2023
Kind
B2
Abstract

Described are multifocal contact lenses that contain high energy visible (HEV) light absorbing compounds and their use for improving one or more vision attributes.

Claims (39)

1. A contact lens that is a free radical reaction product of a reactive mixture comprising:

one or more polymerizable compounds suitable for making the contact lens; and

a high energy visible (HEV) light absorbing compound,

wherein the contact lens is a multifocal contact lens,

and wherein the high energy visible light absorbing compound comprises a compound of formula I:

wherein:

m and n are independently 0, 1, 2, 3, or 4;

T is a bond, O, or NR;

Y is a linking group;

P g is a polymerizable group;

R at each occurrence is independently H, C 1 -C 6 alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, or Y—P g ; and

R 1 and R 2 , when present, are independently at each occurrence C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 thioalkyl, C 3 -C 7 cycloalkyl, aryl (preferably unsubstituted phenyl or phenyl substituted with alkyl or halo), halo, hydroxy, amino, NR 3 R 4 , or benzyl, wherein R 3 and R 4 are independently H or C 1 -C 6 alkyl, or two adjacent R 1 or R 2 groups, together with the carbon atoms to which they are attached, combine to form a cycloalkyl or aryl ring.

2. The contact lens of claim 1 that transmits from 0 percent to 70 percent of light across a wavelength range of 400 to 409 nm.

3. The contact lens of claim 1 that transmits 45 percent or less of light across a wavelength range of 280 to 399 nm.

4. The contact lens of claim 1 that transmits at least 80 percent of light across a wavelength range of 450 to 800 nm.

5. The contact lens of claim 1 that is photostable.

6. The contact lens of claim 1 that is a multifocal toric contact lens.

7. The contact lens of claim 1 wherein the high energy visible light absorbing compound is a static compound.

8. The contact lens of claim 1 wherein m and n are each independently 0 or 1.

9. The contact lens of claim 1 wherein Y at each occurrence is independently alkylene, cycloalkylene, heterocycloalkylene, arylene, heteroarylene, oxaalkylene, alkylene-amide-alkylene, alkylene-amine-alkylene, or combinations thereof.

10. The contact lens of claim 1 wherein P g comprises styryl, vinyl carbonate, vinyl ether, vinyl carbamate, N-vinyl lactam, N-vinylamide, (meth)acrylate, or (meth)acrylamide.

11. The contact lens of claim 1 further comprising a UV absorbing compound.

12. The contact lens of claim 11 wherein the UV absorbing compound comprises a compound of formula I, a benzophenone, a benzotriazole, a triazine, a substituted acrylonitrile, a salicyclic acid derivative, a benzoic acid derivative, a cinnamic acid derivative, a chalcone derivative, a dypnone derivative, a crotonic acid derivative, or mixtures thereof.

13. The contact lens of claim 1 wherein the polymerizable compound suitable for making the contact lens comprises a hydrophilic component, a silicone-containing component, or mixtures thereof.

14. A method for improving a vision attribute in a presbyopic contact lens wearer, the method comprising: providing the presbyopic contact lens wearer with a contact lens according to claim 1 , wherein the vision attribute is selected from one or more of quality of vision, clarity of vision, glare reduction, reduction of squinting, and chromatic contrast.

15. The method of claim 14 wherein improving a vision attribute comprises an improvement in the vision attribute as observed by a presbyopic contact lens wearer when compared to a multifocal contact lens that does not contain a HEV light absorbing compound.

16. The contact lens of claim 1 , wherein the HEV light absorbing compound comprises: 2-(2-cyano-2-(9H-thioxanthen-9-ylidene)acetamido)ethyl methacrylate; 2-(2-cyano-2-(9H-thioxanthen-9-ylidene)acetamido)ethyl acrylate; N-(2-(2-cyano-2-(9H-thioxanthen-9-ylidene)acetamido)ethyl)methacrylamide; N-(2-(2-cyano-2-(9H-thioxanthen-9-ylidene)acetamido)ethyl)acrylamide; 2-(2-cyano-N-methyl-2-(9H-thioxanthen-9-ylidene)acetamido)ethyl methacrylate; 2-cyano-2-(9H-thioxanthen-9-ylidene)-N-(2-(N-vinylacetamido)ethyl)acetamide; 2-(2-cyano-2-(9H-thioxanthen-9-ylidene)acetamido)-2-methylpropyl methacrylate; (E)-2-(2-cyano-2-(2,4-dichloro-9H-thioxanthen-9-ylidene)acetamido)ethyl methacrylate; (E)-2-(2-(2-chloro-9H-thioxanthen-9-ylidene)-2-cyanoacetamido)ethyl methacrylate; (E)-2-(2-cyano-2-(2-isopropyl-9H-thioxanthen-9-ylidene)acetamido)ethyl methacrylate; (E)-2-(2-cyano-2-(4-isopropyl-9H-thioxanthen-9-ylidene)acetamido)ethyl methacrylate; 2-(2-cyano-2-(9H-thioxanthen-9-ylidene)acetoxy)ethyl methacrylate; or mixtures thereof.

17. A method for improving a vision attribute in a presbyopic contact lens wearer, the method comprising:

providing the presbyopic contact lens wearer with a multifocal contact lens that is a free radical reaction product of a reactive mixture comprising:

one or more polymerizable compounds suitable for making the contact lens; and

a high energy visible (HEV) light absorbing compound, wherein the vision attribute is selected from one or more of quality of vision, clarity of vision, glare reduction, reduction of squinting, and chromatic contrast,

and wherein the high energy visible light absorbing compound comprises a compound of formula I:

wherein:

m and n are independently 0, 1, 2, 3, or 4;

T is a bond, O, or NR;

Y is a linking group;

P g is a polymerizable group;

R at each occurrence is independently H, C 1 -C 6 alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, or Y—P g ; and

R 1 and R 2 , when present, are independently at each occurrence C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 1 -C 6 thioalkyl, C 3 -C 7 cycloalkyl, aryl (preferably unsubstituted phenyl or phenyl substituted with alkyl or halo), halo, hydroxy, amino, NR 3 R 4 , or benzyl, wherein R 3 and R 4 are independently H or C 1 -C 6 alkyl, or two adjacent R 1 or R 2 groups, together with the carbon atoms to which they are attached, combine to form a cycloalkyl or aryl ring.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2020
From: MAHADEVAN, SHIVKUMAR; WRIGHT, DAWN D.; CLARK, RONALD J.; KARKKAINEN, THOMAS R.; NANKIVIL, DEREK
To: JOHNSON & JOHNSON VISION CARE, INC.
Reel/Frame 053379/0409 →
Continuity (2)
Provisional Application 62894015 · Aug 30, 2019
Related Publication 20210063770A1 · Mar 4, 2021
Cited By (10)
US 12,481,173 US 12,486,348 US 12,486,403 US 12,497,379 US 12,509,428 US 12,534,623 US 12,595,370 US 12,595,371 US 12,624,214 US 12,674,032